Michel van Kruchten

Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast Cancer

Michel van Kruchten, Elisabeth G.E. de Vries, Andor W.J.M. Glaudemans et al. · Cancer Discovery · 2014 · 231 citations

Medicine, Nuclear Medicine, Oncology +17

PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma

Michel van Kruchten, Andor W.J.M. Glaudemans, Erik F. J. de Vries et al. · Journal of Nuclear Medicine · 2012 · 165 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Hormone receptors as a marker of poor survival in epithelial ovarian cancer

Michel van Kruchten, Pauline van der Marel, Linda de Munck et al. · Gynecologic Oncology · 2015 · 62 citations

Medicine, Gynecology, Oncology +16

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies

Clasina M. Venema, Lemonitsa H. Mammatas, Carolina P. Schröder et al. · Journal of Nuclear Medicine · 2017 · 61 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Positron emission tomography of tumour [18F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy

Michel van Kruchten, Andor W.J.M. Glaudemans, Erik F. J. de Vries et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 59 citations · Full text

Medicine, Nuclear Medicine, Oncology +17